Skip to main content

Gary Huff

Laboratory Corporation of America has promoted Gary Huff to CEO of LabCorp Diagnostics, one of its two primary business segments, effective immediately. Huff most recently served as head of LabCorp Diagnostics' Hospitals and Health Systems group. He also will be a member of the LabCorp executive committee and will report to LabCorp Chairman and CEO David King. The firm's Covance Drug Development business segment is led by John Ratliff.